Sun Pharmaceutical Industries Limited — Others, 06-08-2025: News Verification

Sun Pharmaceutical Industries has clarified that it is not among the global pharmaceutical companies that received letters from the US President seeking lower drug prices, as reported by moneycontrol.com. The company stated there is no specific internal development causing its recent share price decrease. The news report also does not involve Sun Pharma in any legal proceedings. Since the company is not a party to the reported action, it is unable to provide further comments. This update assures investors that the market event does not directly impact Sun Pharma.